MedPath

Identification of sentinel lymph node with infrared fluorescence in lung cancer

Not Applicable
Conditions
lung cancer
Registration Number
JPRN-UMIN000026155
Lead Sponsor
Institute of Biomedical Sciences, Tokushima University Graduate School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

The patient without tolerance for segmentectomy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary endpoint is to assess sensitivity and specificity of sentinel lymph node identification. Standard operation for lung cancer (lobectomy and lymph node dissection) would be performed, and compare metastatic status of sentinel lymph node with that of the other mediastinal lymph node by postoperative histopathological examination.
Secondary Outcome Measures
NameTimeMethod
To assess adverse effect for local injection of ICG.
© Copyright 2025. All Rights Reserved by MedPath